Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-08-14Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma
-
CLINICAL_TRIALS study record update · 2012-08-03(Inhibition of NF-kB Signaling in Melanoma Therapy) A Phase I/II Clinical Trial of PS-341, a Proteasome Inhibitor, in Combination With an Extended Continuous Oral Schedule of Temozolomide in Patients With Advanced Refractory Solid Tumors With the Phase II Component Only in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2012-08-02A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Superficial Groin Dissection in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2012-07-02A Phase 3, Open Label, Randomized, Comparative Study Of CP-675,206 And Either Dacarbazine Or Temozolomide In Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-14Phase II Study in Metastatic Melanoma Using Lymphocytes Reactive With the gp100 Antigen and Immunization Using a Recombinant rF-gp100P209 Virus Encoding a gp100 Peptide Following a Nonmyeloablative Lymphocyte Depleting Regimen
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-06-08Phase I/II Study of Haploidentical Natural Killer Cell Infusion in Patients With Refractory or Relapsed Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-07A Phase II, Multicenter, Open-Label Study of YM155 in Subjects With Unresectable Stage III or Metastatic (Stage IV) Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-07Phase I/II Study Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Allogeneic Tumor-Reactive Lymphocyte Cell Line DMF5 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-06An Open Label, Randomized Clinical Comparability Study Of The Current Liquid And Commercial Liquid Formulations
-
CLINICAL_TRIALS study record update · 2012-06-06A Phase 1, Open Label, Single Arm Study To Establish The Safety Of Administering CP 675,206 As A One Hour Infusion In Patients With Surgically Incurable Stage III Or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2012-05-04Evaluation of Two Different Schedules of Palonosetron for the Prevention of Nausea and Vomiting in Patients With Metastatic Melanoma Receiving Concurrent Biochemotherapy
-
CLINICAL_TRIALS study record update · 2012-04-25An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2012-04-19A Phase II Trial of Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
-
CLINICAL_TRIALS study record update · 2012-04-18Biochemotherapy With Temozolomide, Velban, Cisplatin, Interleukin-2, Interferon-alpha and Thalidomide for Metastatic Melanoma With Optional Intrathecal Interleukin-2 Treatment
-
CLINICAL_TRIALS study record update · 2012-04-11A Phase I Open-label Study of the Safety and Immunogenicity of Escalating Doses of Lipovaxin-MM, a Novel Melanoma Immunotherapeutic, in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-04-04A Prospective Phase II Study of Radiation Therapy and Concurrent Cisplatin Chemotherapy in the Treatment of Locally Advanced or Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2012-03-30Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-03-28PET-CT in the Management of Patients With Stage III Or IV Metastatic Melanoma Considered Candidates for Surgery: Evaluation of Additive Value Following Conventional Imaging
-
CLINICAL_TRIALS study record update · 2012-03-26Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel
-
CLINICAL_TRIALS study record update · 2012-02-22A Pilot Study Assessing the Feasibility and Safety of Measuring Interstitial Fluid Pressure (IFP) in Patients With Advanced Malignant Melanoma Before Starting Systemic Treatment
-
CLINICAL_TRIALS study record update · 2012-01-26IPI-Biotherapy for Patients With Metastatic Melanoma Previously Treated With Cytotoxic Drugs
-
CLINICAL_TRIALS study record update · 2011-12-13Adjuvant Therapy for Melanoma Patients With Regional Lymph Node Metastases With Interferon Alfa-2B vs. Biochemotherapy Using Cisplatin + Vinblastine + DTIC + Interferon Plus IL-2
-
CLINICAL_TRIALS study record update · 2011-11-21A Phase I, Multiple Ascending Dose Study of BMS-663513 (Anti CD137) in Combination With Ipilimumab (BMS-734016/Anti-CTLA-4) in Subjects With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2011-11-08A Phase II Study of Tesetaxel as Second-line Therapy for Subjects With Advanced Melanoma and Normal Serum LDH
-
CLINICAL_TRIALS study record update · 2011-11-07A Pilot Study of Abraxane® (Albumin-bound Paclitaxel) and Temodar® (Temozolomide) Plus Genasense® (Oblimersen Sodium) in Subjects With Advanced Melanoma ("The ATG Study").